FDA Issues Recall of Zantac

The U.S. Food and Drug Administration (FDA) issued an announcement on April 1, 2020, that it is implementing a full recall of all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. The brand name for these drugs is Zantac, the popular heartburn medication. There are concerns that the medication could introduce a cancer-causing…

read more